Related Experiment Video
Updated: Dec 26, 2025
03:53
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
981
Recent advances in chronic granulomatous disease
Gummadi Anjani1, Pandiarajan Vignesh1, Vibhu Joshi1
1Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Genes & Diseases
|March 18, 2020
Summary
Chronic granulomatous disease (CGD) involves defective NADPH oxidase, impairing infection clearance and causing recurrent infections. Research explores its impact on innate immunity, inflammation, and genetic defects like EROS and CYBB carriers.
Area of Science:
- Immunology
- Genetics
- Pathology
Background:
- Chronic granulomatous disease (CGD) is an inherited phagocyte disorder caused by defective NADPH oxidase.
- This defect impairs the production of oxygen free radicals, leading to recurrent bacterial and fungal infections.
- CGD patients also experience inflammatory complications, including granulomas and hemophagocytic lymphohistiocytosis.
Purpose of the Study:
- To review the role of NADPH oxidase in innate immunity and infection pathogenesis in CGD.
- To elucidate the mechanisms underlying non-infective inflammatory complications in CGD.
- To discuss clinical and molecular features of specific genetic defects, including p40phox, EROS, and CYBB carriers.
Main Methods:
- Review of studies on toll-like receptor pathways and neutrophil extracellular traps in CGD.
- Analysis of research on efferocytosis, autophagy, and inflammasome activation in CGD pathogenesis.
- Discussion of clinical and molecular data for p40phox defects, EROS, and CYBB carriers.
Main Results:
- NADPH oxidase plays a crucial role in innate immunity and combating infections in CGD.
- Defective efferocytosis, autophagy, and inflammasome activation contribute to non-infective inflammation in CGD.
- Specific genetic defects like EROS and CYBB mutations present distinct clinical phenotypes.
Conclusions:
- Understanding NADPH oxidase function is key to managing CGD infections.
- Further research into efferocytosis, autophagy, and inflammasome pathways is vital for CGD inflammation.
- Detailed characterization of genetic defects improves diagnosis and management of CGD and its carriers.
More Related Videos
Related Concept Videos
01:24Cystic Fibrosis: Management
384
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
384
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.0K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
01:23Cystic Fibrosis: Pathogenesis
646
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
646